Total Raised

$47.9M

Investors Count

10

Deal Terms

3

Funding, Valuation & Revenue

9 Fundings

nContact Surgical has raised $47.9M over 9 rounds.

nContact Surgical's latest funding round was a Acquired for on October 5, 2015.

nContact Surgical's latest post-money valuation is from October 2015.

Sign up for a free demo to see nContact Surgical's valuations in October 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/5/2015

Acquired

$XXM

0

FY undefined

7

3/8/2013

Series E

$XXM

$XXM

0

FY undefined

10

1/23/2012

Debt - II

$XXM

$XXM

0

FY undefined

0

11/11/2010

Series D

$XXM

$XXM

0

FY undefined

0

8/5/2010

Debt

$XXM

$XXM

0

FY undefined

0

Date

10/5/2015

3/8/2013

1/23/2012

11/11/2010

8/5/2010

Round

Acquired

Series E

Debt - II

Series D

Debt

Amount

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

7

10

0

0

0

Start free trial
New call-to-action

nContact Surgical Deal Terms

3 Deal Terms

nContact Surgical's deal structure is available for 3 funding rounds, including their Acquired from October 05, 2015.

Round

Acquired

Series D

Series B

Funding Date

$XXM

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

$XXM

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

$XXM

Dividend Rate

$XXM

Liquidation Preferences

$XXM

Liquidation Price

Participation

Conversion Price

Anti Dilution

$XXM

General Voting

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$XXM

$XXM

$XXM

$XXM

Series D

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

nContact Surgical Investors

10 Investors

nContact Surgical has 10 investors. AtriCure invested in nContact Surgical's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/5/2015

10/5/2015

1
Acquired

Corporation

Ohio

10/11/2006

3/8/2013

5
Series B, Series C (2009), Debt (2010), Debt - II (2012), Series E (2013)

Venture Capital

North Carolina

10/11/2006

3/8/2013

5
Series B, Series C (2009), Debt (2010), Debt - II (2012), Series E (2013)

Venture Capital

Tennessee

00/00/0000

00/00/0000

Finistere Ventures

Subscribe to see more

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Harbert Growth Partners

Subscribe to see more

Growth Equity

Alabama

First funding

10/5/2015

10/11/2006

10/11/2006

00/00/0000

00/00/0000

Last Funding

10/5/2015

3/8/2013

3/8/2013

00/00/0000

00/00/0000

Investor

Finistere Ventures

Harbert Growth Partners

Rounds

1
Acquired
5
Series B, Series C (2009), Debt (2010), Debt - II (2012), Series E (2013)
5
Series B, Series C (2009), Debt (2010), Debt - II (2012), Series E (2013)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

Venture Capital

Venture Capital

Venture Capital

Growth Equity

Location

Ohio

North Carolina

Tennessee

California

Alabama

New call-to-action

Compare nContact Surgical to Competitors

E
Es Vascular

Es Vascular provides medical solutions within the cardiovascular and surgical sectors. The company offers a range of products including devices for cardiac rhythm management, electrophysiology, heart failure management, urogynecology, gynecology, gastrostomy, specialized surgery, tissue regeneration, and biopsy procedures. Es Vascular serves healthcare professionals and institutions in the medical sector. It was founded in 2000 and is based in Israel.

T
TransCorp

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.

T
TissueLink Medical

TissueLink Medical is a developer and distributor of medical devices that for surgical procedures. The company's technology aims to eliminate the need for multiple technologies with the potential to reduce operating room and patient recovery time by enabling precise coagulation and cutting, with no excess damage to tissue. These devices will be used in general and thoracic surgical procedures.

F
Focal

Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the company's polymer technology. The company's FocalSeal-L and FocalSeal-S surgical sealant products are currently being developed for use inside the body to seal leaks resulting from lung, neurological, cardiovascular and gastrointestinal surgery.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

M
Medtrex

Medtrex develops, manufactures and markets reusable electrosurgical products and other unique surgical devices.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.